The DSM-5 Task Force’s handling of the ethical controversy over the bereavement exclusion demonstrates the need for more inclusive deliberative processes.
AMA J Ethics. 2017;19(2):192-198. doi:
10.1001/journalofethics.2017.19.2.pfor2-1702.
Mark G. Kuczewski, PhD, Johana Mejias-Beck, MD, and Amy Blair, MD
Patients’ immigration concerns can be addressed when clinicians adopt a public health approach to caring: wearing buttons, distributing brochures, inviting experience sharing, and directing patients to needed resources.
AMA J Ethics. 2019;21(1):E78-85. doi:
10.1001/amajethics.2019.78.
Kristen N. Pallok and David A. Ansell’s “Should Clinicians Be Activists?” highlights how physician activists risk retaliation from “economically and socially” privileged physician leaders and organizational leadership who “have been trained to comply” with structural inequity.
AMA J Ethics. 2022;24(7):E694-696. doi:
10.1001/amajethics.2022.694.
Clinical needs of patients with disabilities are seen with the “medical gaze,” a depersonalized lens of evidence-based medicine and of presumed objectivity.
AMA J Ethics. 2023;25(1):E85-87. doi:
10.1001/amajethics.2023.85.
Underlying ideological foundations of stigma and equipment inadequacy include thin-centrism and inadequate representation of fat people in health care organizational leadership.
AMA J Ethics. 2023;25(7):E528-534. doi:
10.1001/amajethics.2023.528.
Disparities in children’s mental health care could be addressed through expansion of school-based programs via passage of the Mental Health in Schools Act.
AMA J Ethics. 2016;18(12):1218-1224. doi:
10.1001/journalofethics.2016.18.12.pfor1-1612.
The FDA's decision to put a black-box warning on antidepressant labels may be misleading because it implies that antidepressants have definitely been found to increase suicidality in adolescents, when in fact there is merely a lack of clear evidence about their safety.